Registration Decision RD2021-01, Trifludimoxazin, Vulcarus and Voraxor

This decision is consistent with the Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor, which contains a detailed evaluation of the information submitted in support of this registration.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-03-27

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data